Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | FDPS | P14324 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NAMPT | P43490 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9538094 | 0.98 | LOXL2 (0.46) | LOXL2ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL9478965 | 0.98 | LOXL2 (0.46) | LOXL2ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| Hydrochloric Acid SCHEMBL27648326 | 0.90 | LOXL2 (0.40) | LOXL2ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| Hydrochloric Acid SCHEMBL10417772 | 0.84 | CHKA (0.39) | LOXL2ALDH1A1LMNASMN1; SMN2MAPT | |
| Phenylmethanesulfonic Acid SCHEMBL3538486 | 0.83 | CA1 (0.47) | ALDH1A1HSD17B10LMNASMN1; SMN2MAPT | |
| SCHEMBL8474031 | 0.82 | CA2 (0.41) | CYP1A2CYP2D6HSD17B10SMN1; SMN2MAPT | |
| SCHEMBL28476775 | 0.80 | LOXL2 (0.46) | LOXL2ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| Sulfuric Acid SCHEMBL9494104 | 0.79 | LOXL2 (0.73) | LOXL2ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL819155 | 0.77 | KMT2A (0.53) | LOXL2ALDH1A1LMNASMN1; SMN2L3MBTL1 | |
| Pyridine SCHEMBL31212672 | 0.77 | KMT2A (0.46) | ALDH1A1CYP3A4LMNASMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112679967-A | Novel active antibacterial food packaging material and preparation method thereof | 温州乐成塑业有限公司 | 2021-04-20 | — | — | CN | claimed |
| EP-2578577-A1 | Sulfonyl esters of tetrahydrocannabinol and derivatives thereof | Albany Molecular Research, Inc. (US) | 2013-04-10 | — | — | EP | claimed |
| US-7674922-B2 | Process for production of delta-9-tetrahydrocannabinol | ALBANY MOLECULAR RESEARCH, INC. (US) | 2010-03-09 | — | — | US | claimed |
| EP-1928853-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR Technology, Inc. (US) | 2008-06-11 | — | — | EP | claimed |
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | AMR TECHNOLOGY, INC. (US) | 2007-04-26 | — | — | US | claimed |
| WO-2007041167-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR TECHNOLOGY, INC. (US) | 2007-04-12 | — | — | WO | claimed |
| WO-2023183613-A2 | INDOLIZINE COMPOUNDS FOR THE TREATMENT OF MENTAL DISORDERS OR INFLAMMATION | TACTOGEN INC (US) | 2023-09-28 | — | — | WO | disclosed |
| CN-112679967-A | Novel active antibacterial food packaging material and preparation method thereof | 温州乐成塑业有限公司 | 2021-04-20 | — | — | CN | disclosed |
| CN-105555780-B | SYK inhibitors | 吉利德科学公司 | 2018-01-23 | — | — | CN | disclosed |
| CN-104119242-A | Improved amino lipids and methods for the delivery of nucleic acids | TEKMIRA PHARMACEUTICALS CORP | 2014-10-29 | — | — | CN | disclosed |
| CN-102245590-B | Improved amino lipids and methods of delivering nucleic acids | TEKMIRA PHARMACEUTICALS CORP | 2014-03-19 | — | — | CN | disclosed |
| EP-2578561-A1 | Processes for the production of cannabidiol derivatives and intermediates thereof | Albany Molecular Research, Inc. (US) | 2013-04-10 | — | — | EP | disclosed |
| EP-2578577-A1 | Sulfonyl esters of tetrahydrocannabinol and derivatives thereof | Albany Molecular Research, Inc. (US) | 2013-04-10 | — | — | EP | disclosed |
| EP-1928853-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR Technology, Inc. (US) | 2008-06-11 | — | — | EP | disclosed |
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | AMR TECHNOLOGY, INC. (US) | 2007-04-26 | — | — | US | disclosed |
| WO-2007041167-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR TECHNOLOGY, INC. (US) | 2007-04-12 | — | — | WO | disclosed |
| CN-1276917-C | Method for synthesizing compound in condensed carbonyl group | BAIHUA PERFUME CO LTD GUANGZHO (CN) | 2006-09-27 | — | — | CN | disclosed |
| CN-1562998-A | Method for synthesizing compound in condensed carbonyl group | BAIHUA PERFUME CO LTD GUANGZHO (CN) | 2005-01-12 | — | — | CN | disclosed |
| US-4952397-A | HAVING PYRIDINIUM GROUP; ADMINISTERED WITH A DEHYDROPEPTIDASE INHIBITOR | MERCK & CO., INC. (US) | 1990-08-28 | — | — | US | disclosed |
| EP-0376355-A1 | 2-Quaternary heteroarylalkythio carbapenems | MERCK & CO. INC. (US) | 1990-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | CNR2, CNR1, HRH4 | LOXL2 2392/4885ALDH1A1 2849/4885CYP1A2 753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.